With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|E2A translocations in pediatric leukemia: developing new therapeutic targets||Children's Hospital of Philadelphia / Bruce Fischer, MD||Young Investigator Grants||2007||Pennsylvania|
|The Role of PASG in Mediating Epigenetic Change and Outcome in AML.||The Johns Hopkins University School of Medicine / Jason Farrar, MD||Young Investigator Grants||2007||Maryland|
|An Exploration of the Medulloblastoma and Glioblastoma Genomes: A Critical Analysis of Candidate Cancer Genes as Potential Molecular Targets for Diagnostics and Therapeutics||The Johns Hopkins University School of Medicine / Will Parsons, MD, PhD||Young Investigator Grants||2007||Maryland|
|Immunotherapy for Osteosarcoma and Ewing sarcoma||Baylor College of Medicine / Nabil Ahmed, MD, MSc||Young Investigator Grants||2007||Texas|
|Generation of a novel oncolytic virus for treatment of pediatric brain tumors.||The Ohio State University / Balveen Kaur, PhD||Young Investigator Grants||2007||Ohio|
|The Identification of Neuroblastoma Cancer Stem Cells.||Stanford University / Robert Cho||Young Investigator Grants||2007||California|
|Developing an accurate genetic model for rhabdomyosarcoma therapy||Children's Research Institute / Dawn Chandler, PhD||Young Investigator Grants||2007||District of Columbia|
|The Role of Inhibition of Apoptosis by C/EBPalpha and C/EBPalpha oncoproteins in AML.||The Johns Hopkins University School of Medicine / Ido Paz-Priel, MD||Young Investigator Grants||2007||Maryland|
|Adoptive immunotherapy using clinical-grade T cells.||University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD||Innovation Grants||2007||Texas|
|Rac in p190-BCR-ABL0Induced Leukemia.||Cincinnati Children's Hospital Medical Center / Jose Cancelas, MD, PhD||Innovation Grants||2007||Ohio|